S-65487

N/A

Report date: 2024/04/16 15:56:23
NME

Base Information

Drug NameS-65487
Drug Alias NameVOB-560S-65487S 65487VOB 560S 65487/VOB 560
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionApoptosis regulator Bcl-2 inhibitorsApoptosis stimulants
TargetsApoptosis regulator Bcl-2
Therapy Area/IndicationsMultiple MyelomaLymphoma, Non-HodgkinLeukemia, Myeloid, Acute +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryPolandHungaryAustralia +[7] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesLes Laboratoires ServierVernalis (R&D) Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAdir SarlInstitut De Recherches Internationales Servier
Inactive CompaniesN/A
Active IndicationsLeukemia, Myeloid, Acute
Inactive IndicationsMultiple MyelomaLymphoma, Non-HodgkinLeukemia, Lymphocytic, Chronic, B-Cell

Other Information

ATC CodeN/A
Related LinksN/A